imdevimab   Click here for help

GtoPdb Ligand ID: 11328

Synonyms: REGN-10987 | REGN10987 | Ronapreve® (imdevimab + casirivimab)
Approved drug
imdevimab is an approved drug (Japan and UK MHRA (2021))
Compound class: Antibody
Comment: Imdevimab is a fully human monoclonal antibody against the surface spike protein of SARS-CoV-2 [1-2]. It is a virus neutralising mAb that was developed by Regeneron.
Click here for help
1. Baum A, Ajithdoss D, Copin R, Zhou A, Lanza K, Negron N, Ni M, Wei Y, Mohammadi K, Musser B et al.. (2020)
REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters.
Science, 370 (6520): 1110-1115. [PMID:33037066]
2. Hansen J, Baum A, Pascal KE, Russo V, Giordano S, Wloga E, Fulton BO, Yan Y, Koon K, Patel K et al.. (2020)
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail.
Science, 369 (6506): 1010-1014. [PMID:32540901]
3. Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, Musser BJ, Soo Y, Rofail D, Im J et al.. (2021)
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.
N Engl J Med, 384 (3): 238-251. [PMID:33332778]